Stockreport

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF with the Low-Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in October as a Late-Breaking Oral Presentation at the 29 th Annual Congress of the Worl [Read more]